Cancer Research UK logo.
SearchDonate
  • Search

A study to find more about acute lymphoblastic leukaemia (UKALL14 sub study)

Overview

Cancer types:

Acute leukaemia, Acute lymphoblastic leukaemia (ALL), Blood cancers, Leukaemia

Status:

Closed

Phase:

Other

Details

This study is open to people who are newly diagnosed with B cell or T cell acute lymphoblastic leukaemia (ALL) and haven’t started treatment. It is a sub study of the original UKALL14 trial.

In particular, it is for

  • adults between 25 and 65 years old with B cell or T cell acute lymphoblastic leukaemia

  • and for people between 19 and 65 who have ALL with the Philadelphia chromosome.

Cancer Research UK supports this study.

Recruitment start: 1 December 2017

Recruitment end: 29 October 2022

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Adele Fielding

Supported by

Cancer Research UK

NIHR Clinical Research Network: Cancer

Novartis

Roche

CRUK & UCL Cancer Trials Centre

Chugai Pharma UK Ltd

Biovitrum

Sigma Tau

Baxalta

Last reviewed: 6 January 2022

CRUK internal database number: 15400

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.